GoodRx Jumps in Debut After $1.14 Billion IPO Surpasses Goal
- Drug-discount, telehealth company valued at $19.4 billion
- Co-CEO Hirsch plans to use proceeds to expand customer base
This article is for subscribers only.
GoodRx Holdings Inc., which operates a telemedicine site and online marketplace for discounts on prescription drugs, rose 53% in its trading debut after exceeding the target on its U.S. initial public offering.
Shares of the Santa Monica, California-based company closed at $50.50 in New York trading Wednesday, giving the company a market value of $19.4 billion.